Is JPMorgan Chase Stock a Buy, Hold or Sell After Earnings?
JPMorgan Chase is trading higher after the big bank topped fourth-quarter earnings expectations, but is the stock a Buy? Here's what you need to know.


JPMorgan Chase (JPM) stock is higher out of the gate Wednesday after the world's largest bank kicked off fourth-quarter earnings season with a bang, beating top- and bottom-line expectations.
In the three months ending December 31, JPMorgan said its revenue increased 9.5% year over year to $43.7 billion, boosted by 17.5% growth in its Commercial & Investment Bank segment to $17.6 billion. Its earnings per share (EPS) rose 58.2% from the year-ago period to $4.81.
The results beat analysts' expectations. Wall Street was anticipating revenue of $41.7 billion and earnings of $4.11 per share, according to CNBC.

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
"The Firm concluded the year with a strong fourth quarter, generating net income of $14.0 billion. Each line of business posted solid results," said JPMorgan CEO Jamie Dimon in a statement. "In Consumer and Community Banking (CCB), we continued to acquire new customers across Consumer Banking, Business Banking, Card, and wealth management. For example, nearly 2 million net new checking accounts were opened during 2024."
JPMorgan ended the quarter with $4 trillion in assets under management and a book value per share of $116.07, representing year-over-year increases of 18% and 11%, respectively.
For fiscal 2025, JPMorgan said it expects to achieve net interest income of approximately $94 billion, an increase of about 1.5% from $92.6 billion in fiscal 2024.
"This was a very good print for the stock, especially as many investors were worried that JPM would be a funding mechanism to chase some of the lower-quality banks out there," wrote David Wagner, portfolio manager at Aptus Capital Advisors, in emailed commentary. "We were most impressed with the company's big revenue beat, and importantly, net interest income was quite strong."
Is JPMorgan stock a buy, sell or hold?
JPMorgan Chase has done well on the price charts over the past 12 months, up 50% on a total return basis (price change plus dividends) vs the S&P 500's 24% gain. Unsurprisingly, Wall Street is bullish on the Dow Jones stock.
According to S&P Global Market Intelligence, the consensus recommendation among the 23 analysts following the financial stock that it tracks is a Buy.
CFRA Research analyst Kenneth Leon is one of those with a Buy rating on the large-cap stock. ""JPM is gaining wallet share across many different core businesses," including investment banking and mergers and acquisitions (M&A), Leon says. "We also see midsize companies looking to shift loans and other services to larger banks like JPMorgan."
Meanwhile, analysts' price targets have had a hard time keeping up with JPM's run higher. The average analyst price target of $254.53 represents implied upside of roughly 2% to current levels. Analysts may revise their price targets higher following the strong quarter.
Related Content
- The Best Bank ETFs to Buy
- Earnings Calendar and Analysis for This Week
- Analysts' Top S&P 500 Stocks to Buy Now
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration.
-
Trump's Immigration Policies and the Price of Home Healthcare: First 100 Days
President Trump's immigration policies may wallop your pocketbook if you rely on a home healthcare aide.
-
Stock Market Today: Stocks Extend a Quiet Winning Streak
The S&P 500 Index could actually close April with a monthly gain, which would be an extraordinary sign of market resilience.
-
Stock Market Today: Stocks Extend a Quiet Winning Streak
The S&P 500 Index could actually close April with a monthly gain, which would be an extraordinary sign of market resilience.
-
How Trump's First 100 Days Have Impacted Your Portfolio
President Trump's first 100 days in office have been busy, with a flurry of executive orders sparking volatility in the stock and bond markets.
-
Is It Still Worth It to Gift Savings Bonds?
Kiplinger editor explores if it's still a good idea to get savings bonds as gifts for children, looking at their returns and usability.
-
Don't Veer Off Course at the First Sign of a Squall in the Markets
When markets go nuts and investor sentiment drops, you can keep your sanity by trusting in and sticking with your long-term plan.
-
How Business Owners Can Prepare for a Terminal Diagnosis
The most important thing is readiness, whether the owner faces a life-changing diagnosis or an employee does.
-
Advisers, Take Note: How 2025 Social Security Changes May Impact Your Clients
What financial advisers might need to know to help their clients navigate Social Security in 2025.
-
Stock Market Today: Have We Seen the Bottom for Stocks?
Solid first-quarter earnings suggest fundamentals remain solid, and recent price action is encouraging too.
-
Social Security Is Taxable, But There Are Workarounds
If you're strategic about your retirement account withdrawals, you can potentially minimize the taxes you'll pay on your Social Security benefits.